3D BioFibR

About 3D BioFibR

3D BioFibR produces collagen fibers using patented dry-spinning technology, enabling the commercial-scale manufacturing of materials that mimic the biomechanical and biochemical properties of natural collagen. These fibers are designed for tissue engineering applications, including 3D bioprinting additives and cellular scaffolds, addressing the need for reliable and scalable biomaterials in regenerative medicine.

```xml <problem> Current methods of producing collagen fibers for tissue engineering struggle to replicate the complex biomechanical and biochemical properties of natural collagen, hindering the development of effective regenerative medicine solutions. Existing manufacturing processes often lack the scalability needed to meet the growing demand for reliable biomaterials in applications like 3D bioprinting and cell culturing. </problem> <solution> 3D BioFibR utilizes a patented dry-spinning technology to produce CollaFibR™, collagen fibers that closely mimic the structure and function of native collagen. Their automated manufacturing system enables the commercial-scale production of these fibers, addressing the limitations of traditional methods. CollaFibR™ serves as a versatile biomaterial for tissue engineering, enhancing the performance of 3D bioprinting additives, hydrogels, and cellular scaffolds used in both 2D and 3D cell and tissue cultures. The technology provides researchers and manufacturers with a consistent and scalable source of high-quality collagen fibers. </solution> <features> - Patented dry-spinning technology for collagen fiber production - Automated manufacturing system enabling commercial-scale production - CollaFibR™ fibers that mimic the biomechanical and biochemical properties of natural collagen - Suitable for use as additives in 3D bioprinting - Compatible with hydrogels for improved tissue engineering applications - Effective as cellular scaffolds for 2D and 3D cell and tissue culture </features> <target_audience> The primary target audience includes researchers and manufacturers in the fields of tissue engineering, regenerative medicine, 3D bioprinting, and cell culture. </target_audience> ```

What does 3D BioFibR do?

3D BioFibR produces collagen fibers using patented dry-spinning technology, enabling the commercial-scale manufacturing of materials that mimic the biomechanical and biochemical properties of natural collagen. These fibers are designed for tissue engineering applications, including 3D bioprinting additives and cellular scaffolds, addressing the need for reliable and scalable biomaterials in regenerative medicine.

Where is 3D BioFibR located?

3D BioFibR is based in Halifax, Canada.

When was 3D BioFibR founded?

3D BioFibR was founded in 2020.

How much funding has 3D BioFibR raised?

3D BioFibR has raised $3.6M.

Who founded 3D BioFibR?

3D BioFibR was founded by Dawn Umlah.

  • Dawn Umlah - Company Builder | Founder Growth Strategist | Board Member
Location
Halifax, Canada
Founded
2020
Funding
$3.6M
Employees
16 employees
Investors
Build Ventures
3B

3D BioFibR

3D BioFibR produces collagen fibers using patented dry-spinning technology, enabling the commercial-scale manufacturing of materials that mimic the biomechanical and biochemical properties of natural collagen. These fibers are designed for tissue engineering applications, including 3D bioprinting additives and cellular scaffolds, addressing the need for reliable and scalable biomaterials in regenerative medicine.

Halifax, CanadaFounded 2020162K+ followers8/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 3 months ago

Funding

$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current methods of producing collagen fibers for tissue engineering struggle to replicate the complex biomechanical and biochemical properties of natural collagen, hindering the development of effective regenerative medicine solutions. Existing manufacturing processes often lack the scalability needed to meet the growing demand for reliable biomaterials in applications like 3D bioprinting and cell culturing.

Solution

3D BioFibR utilizes a patented dry-spinning technology to produce CollaFibR™, collagen fibers that closely mimic the structure and function of native collagen. Their automated manufacturing system enables the commercial-scale production of these fibers, addressing the limitations of traditional methods. CollaFibR™ serves as a versatile biomaterial for tissue engineering, enhancing the performance of 3D bioprinting additives, hydrogels, and cellular scaffolds used in both 2D and 3D cell and tissue cultures. The technology provides researchers and manufacturers with a consistent and scalable source of high-quality collagen fibers.

Target Audience

The primary target audience includes researchers and manufacturers in the fields of tissue engineering, regenerative medicine, 3D bioprinting, and cell culture.

Features

  • Patented dry-spinning technology for collagen fiber production
  • Automated manufacturing system enabling commercial-scale production
  • CollaFibR™ fibers that mimic the biomechanical and biochemical properties of natural collagen
  • Suitable for use as additives in 3D bioprinting
  • Compatible with hydrogels for improved tissue engineering applications
  • Effective as cellular scaffolds for 2D and 3D cell and tissue culture
1
This profile is AI-generated and may contain inaccuracies.